Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MS › Jackson › NPI 1710909585
Hospital

Mississippi Baptist Medical Center, INC.

Mississippi Baptist Medical Center, INC. was paid $42.05M by Medicaid between Jan 2018 and Dec 2024, across 458 billing codes. Its largest line is 99283, emergency room visit (moderate) — 10% of everything it billed.

33Billing provider infoMISSISSIPPI BAPTIST MEDICAL CENTER, INC.
JACKSON, MS 39202
33aNPI1710909585assigned 07/24/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$42.05M
24GClaims1,605,498
24DCodes billed458
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Mississippi

Rank by total paid#9 of 77
Median peer was paid$8.23M
This provider vs. median5.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018222,794$6.03M
2019231,362$6.44M
2020193,634$5.19M
2021238,845$6.02M
2022278,811$6.44M
2023242,943$6.42M
2024incomplete197,109$5.51M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10% 35,068 29,327 $4.33M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.4% 25,929 21,546 $3.93M
G0378 Hospital observation service, per hour 6.9% 8,724 5,656 $2.90M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.6% 13,439 11,245 $2.33M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.0% 16,987 13,907 $1.28M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.9% 15,627 13,212 $1.21M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.5% 9,354 7,784 $1.06M
J9271 Injection, pembrolizumab, 1 mg 2.4% 492 242 $1.01M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.2% 7,441 6,213 $913K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2.1% 8,841 3,902 $876K
78815 Positron emission tomography (PET) for limited area imaging 2.0% 2,371 2,005 $828K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.9% 18,709 15,291 $804K
446 more codes
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.9% 26,338 $790K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.4% 9,247 $595K
95810 Polysomnography; sleep staging with 4 or more additional parameters 1.4% 1,323 $591K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.4% 8,544 $590K
96361 Intravenous infusion, hydration; each additional hour 1.4% 8,566 $570K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.3% 34,512 $554K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1.3% 5,871 $551K
71045 Radiologic examination, chest; single view 1.3% 17,885 $539K
71046 Radiologic examination, chest; 2 views 1.3% 15,246 $537K
78431 1.2% 1,036 $525K
80053 Comprehensive metabolic panel 1.1% 69,158 $447K
86900 <1% 10,500 $417K
D7140 Extraction, erupted tooth or exposed root <1% 1,170 $415K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,220 $389K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 47,647 $368K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 5,015 $337K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 11,007 $324K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 8,333 $320K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 23,696 $290K
96375 Therapeutic injection; each additional sequential IV push <1% 14,020 $283K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 3,513 $281K
95811 <1% 739 $278K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 65,630 $276K
96367 <1% 6,890 $262K
70450 Computed tomography, head or brain; without contrast material <1% 6,824 $260K
88307 <1% 2,190 $245K
D2930 Prefabricated stainless steel crown - primary tooth <1% 3,862 $240K
47563 <1% 120 $229K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 20,748 $209K
86850 <1% 10,667 $204K
J2357 Injection, omalizumab, 5 mg <1% 563 $188K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 6,948 $188K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 6,945 $186K
36415 Collection of venous blood by venipuncture <1% 103,973 $186K
71275 Computed tomographic angiography, chest, with contrast material <1% 2,898 $183K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,381 $177K
83880 <1% 9,799 $176K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 13,128 $176K
11043 <1% 1,283 $161K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,902 $160K
84443 Thyroid stimulating hormone (TSH) <1% 16,039 $150K
78492 <1% 455 $149K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 3,466 $146K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,723 $145K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 9,420 $142K
93017 <1% 2,747 $141K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 2,597 $137K
J2469 Injection, palonosetron hcl, 25 mcg <1% 4,672 $132K
86901 <1% 10,553 $127K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,672 $126K
74018 <1% 3,249 $123K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,033 $121K
88342 <1% 2,903 $121K
81025 <1% 19,943 $119K
J1453 Injection, fosaprepitant, 1 mg <1% 2,361 $115K
80048 Basic metabolic panel (calcium, ionized) <1% 23,652 $108K
76801 <1% 1,566 $105K
86922 <1% 2,792 $105K
80061 Lipid panel <1% 13,238 $102K
73560 <1% 3,006 $99K
36430 <1% 1,143 $98K
81001 <1% 44,565 $96K
84484 <1% 15,597 $96K
93923 <1% 3,026 $95K
87086 Culture, bacterial; quantitative colony count, urine <1% 15,041 $81K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 1,137 $81K
96417 <1% 3,142 $78K
96415 <1% 2,734 $77K
76642 <1% 2,314 $76K
72100 <1% 1,790 $75K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 4,356 $74K
93970 <1% 1,358 $74K
71250 <1% 2,477 $73K
85027 <1% 19,905 $71K
P9016 Red blood cells, leukocytes reduced, each unit <1% 965 $70K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 197 $70K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 443 $65K
83036 Hemoglobin; glycosylated (A1C) <1% 15,216 $65K
99213 Doctor's office visit, returning patient (routine) <1% 2,405 $64K
88304 <1% 2,747 $63K
93971 <1% 2,097 $62K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 949 $61K
73030 <1% 1,888 $56K
73630 <1% 1,569 $56K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 4,691 $55K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,141 $55K
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg <1% 206 $55K
77065 Tomosynthesis, mammo <1% 1,671 $54K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 254 $51K
93880 <1% 1,200 $50K
73610 <1% 1,215 $46K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 102 $45K
73130 <1% 1,036 $43K
88312 <1% 1,798 $43K
83970 <1% 2,317 $43K
77412 <1% 656 $42K
87186 <1% 8,309 $42K
10060 <1% 414 $38K
83690 <1% 8,650 $37K
73502 <1% 1,469 $36K
77066 Tomosynthesis, mammo <1% 742 $36K
70551 Magnetic resonance imaging, brain; without contrast material <1% 463 $33K
36830 <1% 46 $33K
84702 <1% 2,913 $31K
82607 <1% 4,323 $31K
87070 <1% 5,946 $31K
82565 <1% 11,446 $30K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 443 $30K
82550 <1% 5,962 $29K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 527 $28K
86140 <1% 10,699 $28K
82728 <1% 4,144 $28K
93296 <1% 2,754 $28K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,395 $27K
97162 <1% 1,506 $27K
82553 <1% 3,587 $27K
84439 <1% 4,614 $26K
76536 <1% 700 $26K
36600 <1% 1,106 $26K
80074 <1% 1,008 $26K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 229 $26K
83735 <1% 7,220 $26K
86480 <1% 849 $24K
87040 <1% 4,411 $24K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 111 $23K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 78 $22K
82803 <1% 1,807 $21K
87147 <1% 6,176 $21K
85610 <1% 10,098 $21K
87077 <1% 4,317 $20K
77334 <1% 167 $19K
94060 <1% 255 $19K
Q5120 Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg <1% 24 $19K
82746 <1% 2,842 $19K
85007 <1% 8,613 $19K
86235 <1% 2,747 $18K
72125 Computed tomography, cervical spine; without contrast material <1% 734 $17K
77290 <1% 142 $17K
85379 <1% 2,872 $16K
78306 <1% 99 $15K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 592 $15K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 68 $15K
83605 <1% 2,634 $15K
83550 <1% 3,606 $15K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 677 $14K
84703 <1% 2,770 $14K
86038 <1% 1,937 $14K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 22,775 $14K
78264 <1% 75 $14K
86592 <1% 4,472 $13K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 798 $13K
D0272 Bitewings - two radiographic images <1% 13 $13K
70486 <1% 258 $13K
73221 <1% 111 $13K
82570 <1% 5,013 $13K
84132 <1% 5,579 $12K
77370 <1% 223 $12K
94726 <1% 231 $12K
87807 <1% 1,082 $12K
87210 <1% 3,212 $12K
82375 <1% 1,800 $12K
83540 <1% 3,709 $12K
85652 <1% 7,952 $11K
83655 <1% 1,283 $11K
87205 <1% 4,893 $11K
74174 <1% 92 $11K
77336 <1% 300 $11K
80069 <1% 2,789 $10K
96411 <1% 466 $10K
J7030 Infusion, normal saline solution , 1000 cc <1% 14,486 $10K
80076 <1% 1,865 $10K
99214 Doctor's office visit, returning patient (more involved) <1% 418 $10K
97116 <1% 1,215 $10K
86160 <1% 2,106 $9K
88300 <1% 716 $9K
85730 <1% 2,982 $9K
73110 <1% 224 $8K
72141 <1% 130 $8K
86803 <1% 1,031 $8K
82043 <1% 2,330 $8K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 27,095 $8K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 246 $8K
82378 <1% 406 $7K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 106 $7K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 16,826 $7K
74022 <1% 117 $7K
97166 <1% 259 $7K
99204 Doctor's office visit, new patient (more involved) <1% 94 $7K
83050 <1% 1,761 $7K
15004 <1% 35 $7K
84450 <1% 2,558 $7K
72040 <1% 170 $7K
84460 <1% 2,578 $6K
84156 <1% 3,126 $6K
87340 <1% 1,147 $6K
76770 <1% 209 $6K
19083 <1% 13 $6K
77300 <1% 46 $6K
97161 <1% 275 $6K
84100 <1% 2,669 $6K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 11,104 $6K
86431 <1% 1,669 $5K
84550 <1% 2,267 $5K
85045 <1% 2,491 $5K
84165 <1% 1,015 $5K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 214 $5K
97165 <1% 136 $5K
90686 <1% 697 $5K
87420 <1% 421 $4K
D2330 <1% 309 $4K
76830 Ultrasound, transvaginal <1% 63 $4K
70496 <1% 60 $4K
88112 <1% 251 $4K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 5,838 $4K
70498 <1% 77 $4K
86003 <1% 1,519 $4K
82657 <1% 247 $4K
87116 <1% 586 $4K
77080 <1% 159 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 70 $4K
D1120 Dental cleaning, child <1% 500 $4K
85018 <1% 2,131 $3K
86225 <1% 454 $3K
86334 <1% 371 $3K
94010 <1% 104 $3K
99203 Doctor's office visit, new patient (routine) <1% 89 $3K
87206 <1% 1,652 $3K
A9270 Non-covered item or service <1% 8,746 $3K
83615 <1% 817 $3K
82040 <1% 1,399 $3K
J2785 Injection, regadenoson, 0.1 mg <1% 2,251 $3K
88173 <1% 146 $3K
73590 <1% 84 $3K
J7050 Infusion, normal saline solution, 250 cc <1% 10,074 $3K
64450 <1% 34 $3K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 2,108 $3K
87015 <1% 997 $3K
86147 <1% 207 $3K
96416 <1% 24 $2K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 455 $2K
85014 <1% 2,461 $2K
87102 <1% 694 $2K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 12 $2K
86255 <1% 321 $2K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 257 $2K
86769 <1% 92 $2K
88313 <1% 99 $2K
82044 <1% 825 $2K
A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries <1% 1,537 $2K
70491 <1% 16 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 14,816 $2K
J9045 Injection, carboplatin, 50 mg <1% 412 $2K
J0185 Injection, aprepitant, 1 mg <1% 48 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 10,258 $2K
74230 <1% 95 $2K
90662 <1% 555 $2K
83516 <1% 236 $2K
90935 Hemodialysis procedure with single evaluation by a physician <1% 18 $2K
93246 <1% 142 $2K
64447 <1% 25 $2K
99490 Ccm add 20min <1% 141 $2K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 107 $2K
95816 <1% 30 $2K
74220 <1% 27 $2K
84480 <1% 159 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 4,642 $2K
84146 <1% 119 $2K
84155 <1% 978 $2K
82947 <1% 615 $1K
73120 <1% 27 $1K
D1208 Topical application of fluoride, excluding varnish <1% 491 $1K
J2550 Injection, promethazine hcl, up to 50 mg <1% 3,090 $1K
86200 <1% 265 $1K
93299 <1% 114 $1K
72170 <1% 29 $1K
J7120 Ringers lactate infusion, up to 1000 cc <1% 15,313 $1K
20610 <1% 15 $1K
77417 <1% 855 $1K
88360 <1% 90 $1K
74019 <1% 14 $1K
72131 <1% 13 $1K
93280 <1% 88 $1K
88172 <1% 13 $1K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 63 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 9,875 $1K
95806 <1% 42 $1K
74178 <1% 12 $1K
82784 <1% 167 $984.89
C1769 Guide wire <1% 3,072 $974.62
86738 <1% 64 $888.30
75574 <1% 15 $879.70
71270 <1% 12 $875.34
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,659 $867.70
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 16 $852.75
87075 <1% 248 $829.48
85613 <1% 198 $815.08
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 2,769 $801.59
93289 <1% 43 $750.42
83519 <1% 60 $736.08
93288 <1% 58 $731.70
D3220 Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction <1% 38 $724.00
J2704 Injection, propofol, 10 mg <1% 14,205 $719.17
82150 <1% 156 $676.38
87081 <1% 118 $640.26
82962 <1% 276 $616.59
93985 <1% 18 $590.01
86706 <1% 130 $581.62
97760 <1% 12 $536.12
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 4,174 $528.49
75710 <1% 20 $507.62
73070 <1% 14 $501.15
88341 <1% 4,089 $492.19
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 275 $449.55
C1768 Graft, vascular <1% 118 $444.30
82805 <1% 15 $439.16
J0640 Injection, leucovorin calcium, per 50 mg <1% 79 $435.00
P9045 Infusion, albumin (human), 5%, 250 ml <1% 30 $429.27
72110 <1% 13 $427.70
86677 <1% 29 $422.72
J9267 Injection, paclitaxel, 1 mg <1% 115 $385.05
G0379 Direct admission of patient for hospital observation care <1% 44 $368.00
81241 <1% 22 $350.10
86300 <1% 15 $346.95
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 2,690 $346.09
87046 <1% 28 $343.41
92611 <1% 76 $338.40
83020 <1% 36 $321.29
G0442 Annual alcohol misuse screening, 5 to 15 minutes <1% 160 $315.68
96376 <1% 5,122 $313.24
81240 <1% 21 $300.32
86256 <1% 47 $291.77
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 23 $276.08
D0210 Intraoral - complete series of radiographic images <1% 292 $268.74
84403 <1% 13 $250.64
0296T <1% 13 $234.38
86039 <1% 45 $228.44
51702 <1% 13 $220.84
85651 <1% 157 $201.04
C9290 Injection, bupivacaine liposome, 1 mg <1% 944 $200.74
83883 <1% 32 $192.84
99495 <1% 32 $188.49
87088 <1% 30 $183.27
87045 <1% 28 $180.29
77061 <1% 22 $163.54
86762 <1% 17 $161.85
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 10,662 $155.89
G0444 Annual depression screening, 5 to 15 minutes <1% 305 $137.17
90656 <1% 15 $117.70
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 48 $113.90
J2270 Injection, morphine sulfate, up to 10 mg <1% 8,613 $105.69
85598 <1% 19 $97.58
C9113 Injection, pantoprazole sodium, per vial <1% 2,082 $96.62
80177 <1% 14 $95.44
G0008 Administration of influenza virus vaccine <1% 1,004 $92.91
J1171 Injection, hydromorphone, 0.1 mg <1% 201 $88.28
82140 <1% 15 $84.42
C1730 Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) <1% 40 $81.12
99497 <1% 114 $75.31
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg <1% 982 $74.45
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 4,167 $73.71
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 2,378 $59.55
J1650 Injection, enoxaparin sodium, 10 mg <1% 6,482 $56.85
J9190 Injection, fluorouracil, 500 mg <1% 131 $52.08
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 243 $51.31
85660 <1% 15 $47.48
76937 <1% 183 $43.66
84630 <1% 50 $41.21
74300 <1% 108 $41.03
82009 <1% 13 $40.68
94729 <1% 268 $36.78
82310 <1% 13 $36.12
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 913 $34.25
J8540 Dexamethasone, oral, 0.25 mg <1% 62 $31.27
81000 <1% 26 $30.96
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 150 $30.00
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 248 $28.95
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 202 $26.83
96368 <1% 273 $26.36
89051 <1% 12 $25.20
J0690 Injection, cefazolin sodium, 500 mg <1% 10,141 $24.61
84145 <1% 439 $24.12
81003 <1% 12 $23.42
J1940 Injection, furosemide, up to 20 mg <1% 2,052 $17.52
C1781 Mesh (implantable) <1% 107 $14.47
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries <1% 252 $12.72
J1644 Injection, heparin sodium, per 1000 units <1% 5,159 $11.12
J1596 Injection, glycopyrrolate, 0.1 mg <1% 405 $8.12
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 17 $7.28
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 1,999 $7.08
J2720 Injection, protamine sulfate, per 10 mg <1% 14 $7.01
Q4100 Skin substitute, not otherwise specified <1% 82 $6.71
J1956 Injection, levofloxacin, 250 mg <1% 229 $6.60
J0360 Injection, hydralazine hcl, up to 20 mg <1% 1,394 $5.29
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 123 $5.23
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 66 $5.07
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 230 $4.54
J3370 Injection, vancomycin hcl, 500 mg <1% 730 $2.62
90715 <1% 894 $2.61
J3480 Injection, potassium chloride, per 2 meq <1% 59 $2.56
J0736 Injection, clindamycin phosphate, 300 mg <1% 65 $2.31
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 3,236 $2.02
Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml <1% 499 $1.96
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 17 $1.74
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 1,206 $1.03
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,950 $0.92
J2060 Injection, lorazepam, 2 mg <1% 326 $0.45
77063 Screening digital breast tomosynthesis, bilateral <1% 529 $0.43
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 344 $0.03
C1776 Joint device (implantable) 0% 51 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 1,123 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 108 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 1,165 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 88 $0.00
Q9961 High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml 0% 84 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 19 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 17 $0.00
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries 0% 14 $0.00
93356 0% 38 $0.00
G8996 Swallowing functional limitation, current status at therapy episode outset and at reporting intervals 0% 46 $0.00
J0694 Injection, cefoxitin sodium, 1 gm 0% 30 $0.00
G8997 Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 47 $0.00
97150 Therapeutic procedure(s), group (2 or more individuals) 0% 20 $0.00
77062 0% 47 $0.00
A6010 Collagen based wound filler, dry form, sterile, per gram of collagen 0% 14 $0.00
A9504 Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries 0% 20 $0.00
D0220 Intraoral - periapical first radiographic image 0% 13 $0.00
76942 0% 16 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 17 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 317 $0.00
J3490 Unclassified drugs 0% 342 $0.00
A9609 Fludeoxyglucose f18 up to 15 millicuries 0% 262 $0.00
J1815 Injection, insulin, per 5 units 0% 39 $0.00
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 0% 355 $0.00
G0009 Administration of pneumococcal vaccine 0% 99 $0.00
J7121 5% dextrose in lactated ringers infusion, up to 1000 cc 0% 61 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 151 $0.00
J1920 Injection, labetalol hydrochloride, 5 mg 0% 29 $0.00
G8998 Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting 0% 28 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 224 $0.00
11045 0% 101 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 53 $0.00
A4648 Tissue marker, implantable, any type, each 0% 54 $0.00
97802 0% 26 $0.00
J0280 Injection, aminophyllin, up to 250 mg 0% 15 $0.00
A9540 Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries 0% 16 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 153 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDUCKETT, GREGORY (SR VP/ CLO)
Parent organizationBAPTIST MEMORIAL HEALTH CARE CORP.
Same official

Other billing entities under DUCKETT, GREGORY

Full network →
ProviderLocationPaid
Baptist Memorial Hospital - Golden Triangle INC.Columbus, MS$56.02M
Baptist Memorial HospitalMemphis, TN$51.45M
Baptist Memorial Hospital-Desoto, INC,Southaven, MS$41.70M
Baptist Memorial Hospital North Mississippi, INCOxford, MS$38.92M
Baptist Memorial Medical Group INCMemphis, TN$35.67M
Baptist Memorial Hospital Union County, INC.New Albany, MS$32.79M
Anderson Regional Medical CenterMeridian, MS$32.50M
Baptist Memorial Hospital-Jonesboro INCJonesboro, AR$17.05M
Baptist Memorial Hospital-TiptonCovington, TN$13.88M
Northeast Arkansas Clinic Charitable Foundation, INC.Jonesboro, AR$12.83M
Baptist Medical Center - Yazoo, INCYazoo City, MS$11.60M
Baptist Memorial Hospital- Union City INCUnion City, TN$9.08M
Baptist Medical Center-Leake INCCarthage, MS$8.26M
Medical Foundation of Central Mississippi, INC.Jackson, MS$7.52M
Baptist Memorial Hospital-Booneville, INC.Booneville, MS$7.14M
Anderson Regional Medical CenterMeridian, MS$4.16M
Baptist Minor Medical Centers INCMemphis, TN$3.02M
Anderson Physician Alliance, INC.Meridian, MS$2.73M
Baptist Memorial Hospital-HuntingdonHuntingdon, TN$2.49M
Baptist Medical Center-Leake, INC.Carthage, MS$2.23M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.